EUROAPI initiates a $25 million investment for the construction of a state-of-the-art biomass boiler at its Saint-Aubin-lès-Elbeuf (Seine-Maritime, France) site that is planned to be activated in 2025. This investment should enable EUROAPI to support the site’s vitamin B12 production capacity increase program, reduce its CO2 emissions by almost 76% in 2026, compared to 2020 and support the group’s strategy towards greater energy autonomy.

The design and engineering of the biomass boiler have already been finalized and the construction will start in the coming weeks. This 17 MW equipment will use waste wood (Grade B), and is expected to produce 140,000 tons of steam per year, enabling EUROAPI to cut its yearly fossil fuel CO2 emissions by approximately 20,000 tons. It could also allow the production of green electricity by using cogeneration technology, covering 10% of the needs onsite, and supply local community heating networks.

This investment is a key milestone for EUROAPI, in line with its ESG roadmap. It confirms its target to reduce its CO2 emissions (scopes 1 and 2) by 30% in 2030 compared to 2020. In the context of inflation and rising energy prices, this project well illustrates EUROAPI’s strategy towards greater energy autonomy.

This investment benefits from the financial support of $10.5 million from the French Government within the framework of the France Relance plan operated by ADEME. Being awarded by this selection program is a true recognition of EUROAPI’s efforts in favor of decarbonization.

“This major investment in Saint-Aubin-lès-Elbeuf will enable us to reduce our gas consumption and to produce 76% of the total site steam with no CO2 emission in 2025. It bolsters our commitment to delivering our ESG roadmap and more particularly to our industrial process decarbonization initiative,” said Karl Rotthier, CEO, EUROAPI. “I am particularly proud that the quality of this project has allowed the group to be selected by the France Relance program and to benefit from strong financial support.”

The Saint-Aubin-lès-Elbeuf factory is one of the six EUROAPI sites. It is specialized in large scale fermentation and has downstream processing facilities. The plant has health authority, GMP and ISO certifications and operates based on the highest industrial standards. It is the only Western API manufacturing site of vitamin B12 for the pharmaceutical industry and plays a crucial role in ensuring its global supply.